TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
NRIX

Nurix Therapeutics Inc

Healthcare · Biotechnology

23.00$ -2.7% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Nurix Therapeutics Inc (NRIX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 536 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet NRIX
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
308 356 313 511 514 669 615 592 522 688 636 536
268 296 251 450 456 619 564 515 441 607 554 456
42 55 50 117 99 110 76 84 78 247 71 68
259 288 244 443 448 610 550 486 429 593 541 444
2.0 0.8 0.8 0.6 0.8 1.5 9.1 19 1.7 – 2.4 –
0.0 – – – -0.8 – – – – – – –
26 – – – – – – – – – – –
74 155 144 140 137 142 134 144 150 149 155 133
61 87 88 81 86 96 90 76 82 86 92 72
5.4 7.5 7.3 7.9 6.6 8.0 6.6 5.2 3.8 2.8 3.2 3.2
2.2 6.4 5.9 2.8 3.9 11 8.4 6.0 8.6 11 10 12
234 200 169 371 377 527 481 448 372 539 481 403
-503 -545 -587 -631 -680 -739 -795 -839 -925 -1,003 -1,090 -1,180
54 55 55 62 73 78 84 84 84 95 110 111

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?